Crimson Bioenergy logo

CSN.H - Crimson Bioenergy Share Price

C$0.045 0.0  0.0%

Last Trade -

Sector
Basic Materials
Size
Micro Cap
Market Cap £548k
Enterprise Value £554k
Revenue £n/a
Position in Universe th / 2666
Bullish
Bearish
Unlock CSN.H Revenue
Momentum
Relative Strength (%)
1m -9.65%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
0.000 0.000 0.000 0.000 0.018 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2017, Crimson Bioenergy Ltd revenues decreased from C$18K to C$0K. Net loss totaled C$14K vs. income of C$313K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net loss reflects Gain on sale of subsidiary decrease from C$335K (income) to C$0K, Gain on forgiveness of debt decrease from C$48K (income) to C$0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CSN.H Revenue Unlock CSN.H Revenue

Net Income

CSN.H Net Income Unlock CSN.H Revenue

Normalised EPS

CSN.H Normalised EPS Unlock CSN.H Revenue

PE Ratio Range

CSN.H PE Ratio Range Unlock CSN.H Revenue

Dividend Yield Range

CSN.H Dividend Yield Range Unlock CSN.H Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CSN.H EPS Forecasts Unlock CSN.H Revenue
Profile Summary

Crimson Bioenergy Ltd. is a Canada-based company, which intends to invest in technology companies in the United States, Canada and elsewhere. The Company plans to purchase minority positions consisting of shares and/or convertible debentures of these technology companies.

Directors
Last Annual December 31st, 2017
Last Interim December 31st, 2014
Incorporated September 1, 2009
Public Since June 30, 2010
No. of Shareholders: n/a
No. of Employees: 2
Sector Basic Materials
Industry Paper & Forest Products
Index
Exchange TSX Venture Exchange
Shares in Issue 20,587,583
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CSN.H Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CSN.H
Upcoming Events for CSN.H
Frequently Asked Questions for Crimson Bioenergy
What is the Crimson Bioenergy share price?

As of , shares in Crimson Bioenergy are trading at C$0.045, giving the company a market capitalisation of £548k. This share price information is delayed by 15 minutes.

How has the Crimson Bioenergy share price performed this year?

Shares in Crimson Bioenergy are currently trading at C$0.045 and the price has moved by -18.18% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Crimson Bioenergy price has moved by -12.52% over the past year.

What are the analyst and broker recommendations for Crimson Bioenergy?

There are no analysts currently covering Crimson Bioenergy.

When will Crimson Bioenergy next release its financial results?

Crimson Bioenergy is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2015-12-31
What is the Crimson Bioenergy dividend yield?

Crimson Bioenergy does not currently pay a dividend.

Does Crimson Bioenergy pay a dividend?

Crimson Bioenergy does not currently pay a dividend.

When does Crimson Bioenergy next pay dividends?

Crimson Bioenergy does not currently pay a dividend.

How do I buy Crimson Bioenergy shares?

To buy shares in Crimson Bioenergy you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Crimson Bioenergy?

Shares in Crimson Bioenergy are currently trading at C$0.045, giving the company a market capitalisation of £548k.

Where are Crimson Bioenergy shares listed? Where are Crimson Bioenergy shares listed?

Here are the trading details for Crimson Bioenergy:

Country of listing: Canada
Exchange: NEX
Ticker Symbol: CSN.H
What kind of share is Crimson Bioenergy?

We were not able to load our ranking data for Crimson Bioenergy

Is there a Crimson Bioenergy share price forecast 2020?

We were not able to load any forecast data for Crimson Bioenergy.

How can I tell whether the Crimson Bioenergy share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Crimson Bioenergy. Over the past six months, the relative strength of its shares against the market has been -0.78%. At the current price of C$0.045, shares in Crimson Bioenergy are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Crimson Bioenergy PE Ratio?

We were not able to find PE ratio data for Crimson Bioenergy.

Who are the key directors of Crimson Bioenergy?

Crimson Bioenergy's management team is headed by:

William Carr - CEO
Grant Sutherland - DRC
Tom Locke - IND
Garry Renwick - CFO
Who are the major shareholders of Crimson Bioenergy?

Here are the top five shareholders of Crimson Bioenergy based on the size of their shareholding:

Similar to CSN.H
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.